Key statistics
On Thursday, Acumen Pharmaceuticals Inc (ABOS:NSQ) closed at 2.31, 11.06% above the 52 week low of 2.08 set on Jun 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.40 |
---|---|
High | 2.40 |
Low | 2.25 |
Bid | 2.30 |
Offer | 2.60 |
Previous close | 2.37 |
Average volume | 214.54k |
---|---|
Shares outstanding | 60.08m |
Free float | 53.33m |
P/E (TTM) | -- |
Market cap | 142.39m USD |
EPS (TTM) | -1.37 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights
- Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
- Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference
- Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
- Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024
- Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference
- Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
- Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
- Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease
- Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024
More ▼